Methylhomatropinum Bromatum
Methylhomatropinum Bromatum Uses, Dosage, Side Effects, Food Interaction and all others data.
Methylhomatropinum Bromatum is a quaternary ammonium muscarinic acetylcholine receptor antagonist belonging to the group of medicines called anti-muscarinics. Homatropine is used to treat duodenal or stomach ulcers or intestine problems. It can be used together with antacids or other medicine in the treatment of peptic ulcer. It may also be used to prevent nausea, vomiting, and motion sickness.
Methylhomatropinum Bromatum belongs to the group of medicines called anti-muscarinics. Homatropine is used to treat duodenal or stomach ulcers or intestine problems. It can be used together with antacids or other medicine in the treatment of peptic ulcer. It may also be used to prevent nausea, vomiting, and motion sickness.
| Trade Name | Methylhomatropinum Bromatum |
| Generic | Homatropine methylbromide |
| Homatropine methylbromide Other Names | Homatropine methylbromide, Homatropini methylbromidum, Méthylbromure d'homatropine, Methylhomatropine, Methylhomatropine bromide, Methylhomatropinum bromatum, Metilbromuro de homatropina, Omatropina metilbromuro, Tropinium methobromide mandelate |
| Type | |
| Formula | C17H24BrNO3 |
| Weight | Average: 370.281 Monoisotopic: 369.093956286 |
| Groups | Approved |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Uses
Methylhomatropinum Bromatum is a muscarinic receptor antagonist used to treat peptic ulcers, gastric ulcers, and duodenal ulcers.
Used in conjunction with antacids or histamine H2-receptor antagonists in the treatment of peptic ulcers, gastric ulcers and duodenal ulcers, to reduce further gastric acid secretion and delay gastric emptying.
Methylhomatropinum Bromatum is also used to associated treatment for these conditions: Cough
How Methylhomatropinum Bromatum works
Homatropine is a quaternary ammonium muscarinic acetylcholine receptor antagonist. The muscarinic acetylcholine receptor mediates various cellular responses, including inhibition of adenylate cyclase, breakdown of phosphoinositides and modulation of potassium channels through the action of G proteins. Methylhomatropinum Bromatum inhibits the muscarinic actions of acetylcholine on structures innervated by postganglionic cholinergic nerves as well as on smooth muscles that respond to acetylcholine but lack cholinergic innervation. These postganglionic receptor sites are present in the autonomic effector cells of the smooth muscle, cardiac muscle, sinoatrial and atrioventricular nodes, and exocrine glands. Depending on the dose, anticholinergics may reduce the motility and secretory activity of the gastrointestinal system, and the tone of the ureter and urinary bladder and may have a slight relaxant action on the bile ducts and gallbladder.
Food Interaction
No interactions found.Innovators Monograph
You find simplified version here Methylhomatropinum Bromatum
